Pelvic Lymph Node Dissection in Prostate Cancer
نویسندگان
چکیده
Alberto Briganti *, Michael L. Blute , James H. Eastham , Markus Graefen , Axel Heidenreich , Jeffrey R. Karnes , Francesco Montorsi , Urs E. Studer f Department of Urology, Vita-Salute University, Milan, Italy Department of Urology, Mayo Clinic, Rochester, MN, USA Urology Service, Department of Surgery, Memorial Sloan-Kettering Cancer Centre, New York, NY, USA Martini Clinic, Prostate Cancer Centre, Hamburg, Germany Department of Urology, University of Aachen, Aachen, Germany University Hospital of Bern, Department of Urology, Bern, Switzerland e u r o p e a n u r o l o g y 5 5 ( 2 0 0 9 ) 1 2 5 1 – 1 2 6 5
منابع مشابه
Prevalence of Lymph Node Metastasis in Radical Prostatectomy; A Retrospective and Multicenter Study in Iran
Lymph node (LN) metastasis is considered an important prognostic factor in patients with prostate cancer. The aim of this study was to determine the rate of LN metastasis among an Iranian population who underwent radical prostatectomy (RP) with pelvic LN dissection (PLND). In a retrospective review of medical records, 450 RP cases were included and the data on LN metastasis were extracted from ...
متن کاملIs pelvic lymph node dissection required at radical prostatectomy for low-risk prostate cancer?
OBJECTIVES To determine the necessity of pelvic lymph node dissection for low-risk prostate cancer, we analyzed the incidence of lymph node invasion and the therapeutic value of pelvic lymph node dissection in low-risk prostate cancer patients. METHODS Medical records for 1268 patients undergoing open radical prostatectomy between January 2000 and December 2009 who had not undergone neoadjuva...
متن کاملPelvic lymph node dissection in prostate cancer.
The results of pelvic lymph node dissections in 105 prostate cancer patients were analyzed to compare the clinical with the pathologic stages. Twenty-four per cent of patients clinically believed to be node-negative had positive nodal involvement with cancer.
متن کاملProstate Cancer Treatment Protocols
Treatment for patients with clinical stage T1-T2a, Gleason score 2-6, PSA < 10 ng/mL, with a life expectancy < 10y, includes active surveillance Treatment for patients with a life expectancy ≥10y includes active surveillance OR Radical prostatectomy (RP) with or without pelvic lymph node dissection (PLND) if predicted probability of lymph node metastases ≥2%; RP is the standard therapy for loca...
متن کاملSense and Nonsense of an Extended Pelvic Lymph Node Dissection in Prostate Cancer
Lymph node metastases associated with prostate cancer (PCa) has been shown to be a poor prognostic factor. The role of pelvic lymph node dissection (PLND) itself in relation to survival remains unclear, however. A Medline search was conducted to address this issue. The following conclusions were drawn. Only recently, improved survival due to completion of radical prostatectomy (RP) (compared to...
متن کاملنقش پاراآئورتیک لنفادنکتومی در مرحله یک سرطان تخمدان
Background: Surgical staging is the standard treatment of ovarian cancer. Pelvic and para-aortic lymphadenectomy is the important part of the surgery. The aim of this study was to evaluate the effect of para aortic lymph node dissection in early stage of patients with ovarian cancer. Methods: This descriptive cross-sectional cohort study was performed on all stage I of ovarian cancer pati...
متن کامل